Preparation, purification and common characteristics of anticoagulant peptide from peloid

E P Kalinin; D I Boyarintsev; S L Galyan

doi:10.17750/KMJ2015-824

Kazan medical journal ›› 2015, Vol. 96 ›› Issue (5) : 824 -828. DOI: 10.17750/KMJ2015-824

Experimental medicine

research-article

Preparation, purification and common characteristics of anticoagulant peptide from peloid

Author information +

History +

PDF

Abstract

Aim. To obtain the peloid extract containing peptide anticoagulant, to separate it from co-extracted compounds, to confirm the chemical structure of the purified anticoagulant, to characterize the amino acid profile and to evaluate its effect on blood clotting activity in vitro and the effect on hemostasis in laboratory animals. Methods. The anticoagulant was derived from lake Taraskul (Tyumen region) peloid. The effector was prepared and purified by original method including extraction, sedimentation of humic acids by salting-out, and removal of fulvic acids and low molecular weight fractions of humic acids by ion exchange chromatography. Purity and homogeneity of gained anticoagulant was evaluated by high performance liquid chromatography and polyacrylamide gel electrophoresis. The chemical composition of the active substance was determined by acid hydrolysis and identification of phenylthiohydantoin amino acid derivatives by reversed-phase high performance liquid chromatography. Specific anticoagulant activity was evaluated by substance’s influence on effect of thrombin-dependent conversion of fibrinogen to fibrin and serum thrombin clotting time after being administered to laboratory animals. Results. Peptide anticoagulant was isolated of the peloid and purified. Its activity is realized at the stage of thrombin and fibrinogen interaction. The substance prolongs the fibrin clotting time both in a model test system and when administered intravenously to rats. The anticoagulant effect of the peptide when administered to animals lasts at least 60 min, and no significant toxic effects appear. Conclusion. An isolated active substance might be a basis for the drug development of anticoagulants.

Keywords

natural crude drug / analysis / standardization / identification / anticoagulant / peloid

Cite this article

Download citation ▾

E P Kalinin, D I Boyarintsev, S L Galyan. Preparation, purification and common characteristics of anticoagulant peptide from peloid. Kazan medical journal, 2015, 96(5): 824-828 DOI:10.17750/KMJ2015-824

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Бышевский А.Ш., Чирятьев Е.А., Умутбаева М.К. О возможной роли ингибитора самосборки фибрина в регуляции свёртывания крови // Гематол. и трансфузиол. - 1985. - Т. 30, №1. - С. 35-38.

[2]	Дарбре А. Практическая химия белка / Под ред. А. Дарбре. - М.: Мир, 1989. - 621 с.

[3]	Дементьева И.А. Защитное действие недиализующейся фракции экстракта медуницы при угрозе тромбоза / В кн.: Обмен веществ в норме и патологии. / Под ред. А.Ш. Бышевского. - Тюмень: ТюмГМИ, 1992. - С. 30.

[4]	Калинин Е.П., Русакова О.А., Чирятьев Е.А. Способ получения антикоагулянта из сапропеля. Патент на изобретение №RUS2175552 от 16.03.2000.

[5]	Государственный реестр лекарственных средств. - http://www.grls.rosminzdrav.ru (дата обращения: 30.08.2015).

[6]	Суханова Г.А., Меликян А.Л., Вахрушева М.В. и др. Варфариновый некроз кожи у пациента с дефицитом протеина С // Тромбоз, гемостаз и реология. - 2014. - №1. - С. 75-82.

[7]	Чирятьев Е.А., Бышевский А.Ш., Яковлева Н.В., Платонов Е.В. Способ получения средства, обладающего антикоагулянтной активностью Патент на изобретение №RUS2101023 от 10.01.1998.

[8]	Dimova N. RP-HPLC analysis of amino acids with UV-detection // Compter rendus l’Academie bulgare des Sciences. - 2003. - Vol. 56, N 12. - P. 75-78.

[9]	Ellis G., Camm A.J., Datta S.N. Novel anticoagulants and antiplatelet agents; a guide for the urologist // BJU International. - 2015, Mar 23. - doi: 10.1111/bju.13131.